Tuberculosis Market Trends and Innovations
New Drug Development: The Tuberculosis Market has witnessed the development of novel drugs such as bedaquiline and delamanid, which offer hope for patients with drug-resistant TB. These drugs are part of a new generation of treatments that are more effective and have fewer side effects than older medications.
Vaccine Development: The pursuit of an effective TB vaccine has been ongoing for decades. The Bacillus Calmette-Guérin (BCG) vaccine, although imperfect, has been a mainstay in TB prevention. Researchers are working on improving and developing new vaccines, such as the M72/AS01E candidate, to enhance protection against TB.
Diagnostic Advancements: Molecular diagnostic tests, like GeneXpert, have revolutionized TB diagnosis by providing rapid and accurate results. These tests are particularly valuable in resource-limited settings where traditional methods can be slow and less precise.
Digital Health Solutions: Mobile health (mHealth) applications and telemedicine platforms are being increasingly used to monitor TB patients' adherence to treatment regimens and provide support remotely, especially during the COVID-19 pandemic.
If you are interested to know more in-depth details about the report, just visit here @ Tuberculosis Market
